
Number of publications published per year by Lucena, M. I.. (Source : PubMed)

Distribution of publications types for Lucena, M. I.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Pharmacogenomics in drug induced liver injury.
Curr. Drug Metab.
2009;10;9

Rechallenge in drug-induced liver injury: the attractive hazard.
Expert Opin Drug Saf
2009;8;6
Antibiotic-Induced Liver Toxicity: Mechanisms, Clinical Features and Causality Assessment.
Current drug safety
2009

Drug-induced liver injury: insights from genetic studies.
Pharmacogenomics
2009;10;9
Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.
Hepatology
2009;49;6

Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
Clin Ther
2009;31;5


[Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry]
Rev Esp Enferm Dig
2008;100;11
Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.
Hepatology
2008;48;2
Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome.
J. Hepatol.
2008;49;1

[An analysis of the causes, characteristics, and consequences of reexposure to a drug or compound responsible for a hepatotoxicity event]
Rev Esp Enferm Dig
2008;100;5
[ See timeline ] [ See all publications ]
means that Lucena, M. I. has 18 papers cited a least 18 times - methodology
Hepatology Unit, Hospital Universitario Virgen de la Victoria, Facultad de Medicina, Málaga, Spain.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.